跳至主要内容
临床试验/NCT07353125
NCT07353125已完成不适用

Evaluation of the Blood Glucose Monitoring System LS-9 of Leison Biotech Co., Ltd. in Accordance With DIN EN ISO 15197:2015

Institut fur Diabetes Karlsburg GmbH0 个研究点目标入组 219 人开始时间: 2025年7月21日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
219

研究概览

简要总结

This study assesses the system accuracy and performance evaluation by the user of a blood glucose monitoring system pursuant to ISO 15197

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients with hypo-, eu- or hyperglycaemia
  • The written informed consent had to be signed
  • The volunteers must be older than 18 years
  • The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

排除标准

  • Pregnancy or lactation
  • Acute or chronic diseases with the risk of aggravation by the measure
  • A current constitution that does not allow participating in the study
  • Participation in another study or activity with the blood glucose measuring system evaluated in the present study
  • Application of substances listed in Appendix A of DIN EN ISO 15197:2015

研究者

发起方
Institut fur Diabetes Karlsburg GmbH
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthes Kenning

Eckhard Salzsieder, Principal Investigator

Institut fur Diabetes Karlsburg GmbH

相似试验

System Accuracy and Performance Evaluation by the... | 临床试验